Optimal Control Applied to Cell-Cycle-Specific Cancer Chemotherapy
暂无分享,去创建一个
[1] J. M. Murray,et al. Some optimal control problems in cancer chemotherapy with a toxicity limit. , 1990, Mathematical biosciences.
[2] Michael C. Mackey,et al. Unified hypothesis for the origin of aplastic anemia and periodic hematopoiesis , 1978 .
[3] Martin M. Eisen,et al. Mathematical Models in Cell Biology and Cancer Chemotherapy , 1979 .
[4] A Swierniak,et al. Optimal control problems arising in cell‐cycle‐specific cancer chemotherapy , 1996, Cell proliferation.
[5] M. Petit. Dynamic optimization. The calculus of variations and optimal control in economics and management : by Morton I. Kamien and Nancy L. Schwartz. Second Edition. North-Holland (Advanced Textbooks in Economics), Amsterdam and New York, 1991. Pp. xvii+377. ISBN0-444- 01609-0 , 1994 .
[6] G. F. Webb,et al. Resonance phenomena in cell population chemotherapy models , 1990 .
[7] W. Fleming,et al. Deterministic and Stochastic Optimal Control , 1975 .
[8] Z. Agur,et al. A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs. , 1992, Mathematical biosciences.
[9] R. Vidal. Dynamic optimization: The calculus of variations and optimal control in economics and management: Morton I. KAMIEN and Nancy L. SCHWARTZ Volume 4 in: Dynamic Economics: Theory and Applications, North-Holland, New York, 1981, xi + 331 pages, Dfl.90.00 , 1982 .
[10] R E Wittes,et al. Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Hainsworth,et al. Paclitaxel administered by 1‐hour infusion. Preliminary results of a phase 1/11 trial comparing two schedules , 1994, Cancer.
[12] J C Panetta,et al. A mathematical model of breast and ovarian cancer treated with paclitaxel. , 1997, Mathematical biosciences.
[13] E. Eisenhauer,et al. Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer. Canadian-European Taxol Cooperative Trial Group. , 1993, Cancer treatment reviews.
[14] C. Lipschultz,et al. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. , 1993, British Journal of Cancer.
[15] G. F. Webb,et al. Resonances in periodic chemotherapy scheduling , 1995 .
[16] Zvia Agur,et al. Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugs , 1988 .
[17] G. W. Swan. Role of optimal control theory in cancer chemotherapy. , 1990, Mathematical biosciences.
[18] Morton I. Kamien,et al. Dynamic Optimization , 2020, Natural Resource Economics.
[19] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[20] Z. Agur,et al. The Effect of Drug Schedule on Responsiveness to Chemotherapy a , 1987 .
[21] J. M. Murray,et al. Optimal control for a cancer chemotherapy problem with general growth and loss functions. , 1990, Mathematical biosciences.